CAS: 2089293-61-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | NAcM-OPT REF: IN-DA01E74CCAS: 2089293-61-6 | 99% | To inquire | Tue 10 Dec 24 |
 | NAcM-OPT REF: 3D-BN165240CAS: 2089293-61-6 | Min. 95% | 204.00 €~597.00 € | Thu 19 Dec 24 |
 | NAcM-OPT REF: TM-T5374CAS: 2089293-61-6 | 99.68% | 51.00 €~822.00 € | Tue 28 Jan 25 |
Ref: IN-DA01E74C
| 5mg | 137.00 € | ||
| 10mg | 165.00 € | ||
| 25mg | 291.00 € | ||
| 50mg | 653.00 € | ||
| 100mg | To inquire | ||
| 250mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
NAcM-OPT
CAS:2089293-61-6
Inhibits N-Acetyl-mediated interaction between BE2M (E2 conjugating enzyme) and DCN1 (a component of E3 ligase …
Formula:
C23H29Cl2N3O
Purity:
Min. 95%
Color and Shape:
solid.
Molecular weight:
434.4 g/mol
Ref: 3D-BN165240
| 10mg | 204.00 € | ||
| 50mg | 597.00 € |
Estimated delivery in United States, on Thursday 19 Dec 2024
NAcM-OPT
CAS:2089293-61-6
NAcM-OPT is a specific, reversible inhibitor targeting N-Acetyl-UBE2M interaction with DCN1 (IC50: 79 nM).
Formula:
C23H29Cl2N3O
Purity:
99.68%
Color and Shape:
Solid
Molecular weight:
434.4
Ref: TM-T5374
| 5mg | 51.00 € | ||
| 10mg | 78.00 € | ||
| 25mg | 139.00 € | ||
| 50mg | 211.00 € | ||
| 100mg | 355.00 € | ||
| 500mg | 822.00 € | ||
| 1mL*10mM (DMSO) | 52.00 € |
Estimated delivery in United States, on Tuesday 28 Jan 2025
